Literature DB >> 18713255

Clinical heterogeneity in recessive epidermolysis bullosa due to mutations in the keratin 14 gene, KRT14.

E Yiasemides1, N Trisnowati, J Su, N Dang, S Klingberg, P Marr, W Melbourne, K Tran, C W Chow, D Orchard, G Varigos, D F Murrell.   

Abstract

BACKGROUND: Epidermolysis bullosa simplex (EBS), the most common subtype of EB, is usually inherited as an autosomal dominant trait caused by mutations in either the keratin 5 (KRT5) or keratin 14 (KRT14) genes. Recessive EBS (R-EBS) is extremely rare.
METHODS: We present the first Australian patient diagnosed with R-EBS, to our knowledge, and a comprehensive review of genotypes and phenotypes of R-EBS reported cases.
RESULTS: The female proband, of Turkish descent with consanguineous parentage, was referred to us at the age of 8 years. Clinically, she had a severe phenotype including generalized blisters, mucosal involvement and EB naevi. Immunofluorescence mapping and electron microscopy were consistent with a diagnosis of EBS. Staining for Keratin 14 (K14) was negative. The basal layer, however, reacted with monoclonal antibodies to keratins 6 (K6) and 16 (K16). Mutation screening from genomic DNA showed that the proband was homozygous for the truncation mutation Y204X in exon 3 of KRT14, and both unaffected parents were heterozygous for a single KRT14 Y204X mutation. The phenotype of our patient is reported in more detail and with longer follow-up than those of others published in the literature. DISCUSSION: The proband's phenotype was severe as an infant but improved with age, suggesting that an alternative keratin is pairing with K5 in her skin to compensate for the loss of K14--a novel biological compensatory mechanism. It is interesting that K6 and K16 were expressed, as these are normally positive in hyperproliferative skin disorders.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18713255     DOI: 10.1111/j.1365-2230.2008.02858.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  3 in total

1.  Mutations in the gene encoding the RER protein FKBP65 cause autosomal-recessive osteogenesis imperfecta.

Authors:  Yasemin Alanay; Hrispima Avaygan; Natalia Camacho; G Eda Utine; Koray Boduroglu; Dilek Aktas; Mehmet Alikasifoglu; Ergul Tuncbilek; Diclehan Orhan; Filiz Tiker Bakar; Bernard Zabel; Andrea Superti-Furga; Leena Bruckner-Tuderman; Cindy J R Curry; Shawna Pyott; Peter H Byers; David R Eyre; Dustin Baldridge; Brendan Lee; Amy E Merrill; Elaine C Davis; Daniel H Cohn; Nurten Akarsu; Deborah Krakow
Journal:  Am J Hum Genet       Date:  2010-04-01       Impact factor: 11.025

2.  Long-Term Follow-Up Outcomes of 19 Patients with Osteogenesis Imperfecta Type XI and Bruck Syndrome Type I Caused by FKBP10 Variants.

Authors:  Aylin Yüksel Ülker; Dilek Uludağ Alkaya; Leyla Elkanova; Ali Şeker; Evren Akpınar; Nurten Ayşe Akarsu; Zehra Oya Uyguner; Beyhan Tüysüz
Journal:  Calcif Tissue Int       Date:  2021-06-25       Impact factor: 4.333

3.  Molecular Modeling of Pathogenic Mutations in the Keratin 1B Domain.

Authors:  Alexander J Hinbest; Sherif A Eldirany; Minh Ho; Christopher G Bunick
Journal:  Int J Mol Sci       Date:  2020-09-10       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.